Literature DB >> 31144382

An 11-lncRNA expression could be potential prognostic biomarkers in head and neck squamous cell carcinoma.

Qingyong Xu1, Hang Yin1, Haijiao Ao1, Xue Leng2, Mingdong Liu2, Yang Liu2, Jianqun Ma2, Xiaoyuan Wang2.   

Abstract

The aim of our study is to construct the competing endogenous RNA (ceRNA) network of head and neck squamous cell carcinoma (HNSCC) and identify key long noncoding RNAs (lncRNAs) to predict prognosis. The genes whose expression were differentially in HNSCC and normal tissues were explored by the Cancer Genome Atlas database. The ceRNA network was constructed by the Cytoscape software. The lncRNAs which could estimate the overall survival were explored from Cox proportional hazards regression. There are 1997, 589, and 82 mRNAs, lncRNAs, and miRNAs whose expression were statistically significant different, respectively. Then, the network between miRNA and mRNA or miRNA and lncRNA was constructed by miRcode, miRDB, TargetScan, and miRanda. Five mRNAs, 10 lncRNAs, and 3 miRNAs were associated with overall survival. Then, 11-lncRNAs were found to be prognostic factors. Therefore, our research analyzed the potential signature of novel 11-lncRNA as candidate prognostic biomarker from the ceRNA network for patients with HNSCC.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  The Cancer Genome Atlas; biomarker; competing endogenous RNAs network; head and neck squamous cell carcinoma; long noncoding RNAs

Year:  2019        PMID: 31144382     DOI: 10.1002/jcb.29113

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  Identification and Clinical Validation of 4-lncRNA Signature for Predicting Survival in Head and Neck Squamous Cell Carcinoma.

Authors:  Yanping Ji; Yu Xue
Journal:  Onco Targets Ther       Date:  2020-08-21       Impact factor: 4.147

2.  M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway.

Authors:  Hang Yin; Lin Chen; Shiqi Piao; Yiru Wang; Zhange Li; Yuan Lin; Xueqing Tang; Huijuan Zhang; Haiyang Zhang; Xiaoyuan Wang
Journal:  Cell Death Differ       Date:  2021-10-09       Impact factor: 12.067

3.  A prognostic long non-coding RNA-associated competing endogenous RNA network in head and neck squamous cell carcinoma.

Authors:  Chengyao Zhang; Wei Cao; Jiawu Wang; Jiannan Liu; Jialiang Liu; Hao Wu; Siyi Li; Chenping Zhang
Journal:  PeerJ       Date:  2020-09-15       Impact factor: 2.984

4.  Integrated analysis of immune-related genes in endometrial carcinoma.

Authors:  Yiru Wang; Yunduo Liu; Yue Guan; Hao Li; Yuan Liu; Mengjun Zhang; Ping Cui; Dan Kong; Xiuwei Chen; Hang Yin
Journal:  Cancer Cell Int       Date:  2020-10-02       Impact factor: 5.722

5.  Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma.

Authors:  Yiru Wang; Shijie Zhang; Yang Bai; Gen Li; Siyu Wang; Jiayi Chen; Xin Liu; Hang Yin
Journal:  Front Cell Dev Biol       Date:  2022-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.